Skip to search formSkip to main contentSkip to account menu

Harvoni

National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

ledipasvirledipasvir / sofosbuvirsofosbuvir
ledipasvir / sofosbuvir Oral Tablet [Harvoni]ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet [Harvoni]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Harvoni-Induced Deterioration of Renal and Liver Function
A 65 year old African American male was initially evaluated for his ascites. He was found to have cirrhosis of liver secondary to… 
Review
2015
Review
2015
Finding Truth in a World Full of Spin: Myth-Busting in the Case of Sovaldi.
Review
2015
Review
2015
Ledipasvir + sofosbuvir (Harvoni). A therapeutic advance in genotype 1 hepatitis C virus infection, despite uncertainties.
  • Prescrire international
  • 2015
  • Corpus ID: 683228
Treatment for chronic hepatitis C depends on the hepatitis C virus (HCV) genotype and the patient's clinical characteristics. A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)